Clomiphene QB Wed, 18 May 2022 02:33:22 +0000 en-US hourly 1 Clomiphene QB 32 32 Connecticut Medical Board fines doctor $10,000 in prescription case – Hartford Courant Tue, 17 May 2022 20:32:08 +0000

The state medical examination board on Tuesday fined an Oxford doctor $10,000 for fraudulently using another doctor’s name and Drug Enforcement Agency registration number to prescribe drugs. controlled substances to a family member.

In addition to the fine, the council also voted unanimously to reprimand the medical license of the physician, Marc D. Legris, and ordered him to take an ethics course and practice in a supervised practice. The prescription does not indicate the name of the doctor Legris contacted.

In a council-approved consent order, Legris chose not to contest the allegations.

Department of Public Health records show that in August 2021, Legris relinquished his own DEA registration and controlled substance designation in Connecticut. DPH began its investigation after a referral from the state Department of Consumer Protection.

The consent order states that Legris prescribed the drugs to a family member on a recurring basis from August 2018 to August 2021. The relative was not a patient of his and he did not keep medical records for the parent, the order said.

In an unrelated case, the board unanimously voted to fine former Hartford allergist Dr. Michael L. Krall $2,000 and reprimand his medical license, according to state records. for prescribing cough medicine with codeine to a family member six times between May 2017 and May 2020.

The relative was not his patient, and Krall did not keep medical records for the family member, pursuant to a council-approved consent order. Krall, who now lives in Boston and no longer practices medicine in Connecticut, chose not to contest the allegations, the order said. Consumer protection had forwarded the file to the DPH.

This story was reported in partnership with the Connecticut Health I-Team (, a nonprofit news organization dedicated to health reporting.

Source link

FDA approves first non-prescription test for Covid-19, influenza and RSV Tue, 17 May 2022 09:10:04 +0000

The United States Food and Drug Administration (FDA) has approved the first non-prescription test that identifies respiratory viral infections Covid-19, influenza and respiratory syncytial virus (RSV).

The regulatory approval will allow people with symptoms of Covid-19 to purchase the Labcorp Seasonal Respiratory Virus RT-PCR DTC test without a prescription.

Users can then collect a nasal swab sample themselves at home and send it to Labcorp for analysis. The results will be delivered via an online portal.

According to the FDA statement, the Labcorp Seasonal Respiratory Virus RT-PCR DTC test can detect influenza A and B, RSV, and SARS-CoV-2, which is the virus that causes Covid-19.

Director of the FDA Center for Devices and Radiological Health, Jeff Shuren, said: “While the FDA has now authorized many Covid-19 tests without a prescription, this is the first test authorized for influenza and RSV, with Covid-19, where an individual can self-identify their need for a test, order it, collect their sample and send it to the lab for analysis, without consulting a medical professional.

“Rapid advances in consumer access to diagnostic testing, including the ability to collect your sample at home for influenza and RSV without a prescription, bring us one step closer to testing for these viruses that could be done entirely at home.”

Users can purchase the test online or in a store.

The test can be used by people aged 14 and over, as well as adults, although they are advised to collect swabs themselves under adult supervision.

For people two years and older, adult assistance is required.

Recently, the FDA also granted an Emergency Use Authorization (EUA) for Cepheid’s Xpert Xpress CoV-2 plus test.

Related companies

Source link

Legal weed lowers prescription drug use, study finds Sun, 15 May 2022 23:35:37 +0000

This article originally appeared on 2Fast4Buds and appears here with permission.

It has long been suggested and subsequently confirmed by research that passing medical marijuana laws has a significant effect on the volume of drug prescriptions. Now, a team of scientists from Cornell University has discovered that the same thing also happens when a state or territory legalizes recreational use of the substance by adults.

To arrive at these results, the researchers studied data collected by the Centers for Medicare and Medicaid Services in all 50 states between 2011 and 2019. During this period, 18 US states plus the District of Columbia authorized the use of cannabis. for adults, with Colorado and Oregon being the first to do so in 2012.


Consistent with previous findings regarding the legalization of marijuana for medical purposes and in full accordance with the hypothesis proposed by the team, the end of cannabis prohibition leads to the end of the abuse of prescription pharmaceuticals. And since most of these drugs are either expensive or too expensive, their reduced consumption results in significant savings for Medicare and Medicaid.

A larger positive consequence associated with the legalization of cannabis is that many prescription drugs have serious side effects and replacing them with cannabis results in reduced harm and risk to the patient. The overuse of prescription painkillers is particularly dangerous, which has recently led to an opioid crisis that many experts and policymakers are calling an epidemic.


The list of conditions for which prescription volumes drop when cannabis becomes legal include pain, depression, anxiety, sleep, psychosis and seizures. This is yet another circumstantial evidence of the drug’s therapeutic efficacy. Although the study was not designed to provide an explanation for its results, the authors suggest that thanks to the greater availability of cannabis, some people are self-medicating with it instead of going to the doctor first. place. And since most primary care visits result in prescriptions, many Rx blanks remain unfilled.

Source link

NHS England prescription fees frozen for a year Sun, 15 May 2022 10:12:34 +0000 NHS England prescription fees are frozen for a year Credit: Facebook @PharmacyTimes

Health Secretary Sajid Javid has announced that NHS England prescription fees will be frozen for a year, in response to the cost of living crisis.

Javid said the cost of prescriptions normally increases with inflation every year, but there was a need to “put money back in people’s pockets”.

It is understood to be the first time in 12 years that the price has been frozen, saving patients £17million, according to the Department of Health and Social Care (DHSC).

This means that the current cost of £9.35 for a single prescription will remain for another year, as will the £30.25 three-month prescription prepayment certificate (PPC). For those on long-term medicine, the cost will remain at £108.10 for the year, which can be paid in instalments.

The change follows Prime Minister Boris Johnson’s call on ministers to find ways to help reduce the financial strain on families. At his first meeting of the cost of living committee, he urged ministers to be as creative as possible, but that the measures should not require funding from the Treasury.

Javid said: “The rising cost of living is inevitable as we face global challenges and the repercussions of Putin’s illegal war in Ukraine.

“While we cannot completely prevent these increases, where we can help, we absolutely will.

“That’s why I’m freezing dispensing fees to help ease some of those pressures and put money back in people’s pockets.”

The measure comes after the Prime Minister Boris Johnson asked ministers to propose initiatives to reduce the pressure on family budgets caused by soaring world prices.

After the Queen’s Speech on Tuesday, the Prime Minister chaired the first meeting of the government’s cost of living committee.

He urged ministers to be as ‘creative as possible’ in coming up with ideas to help struggling families that would not require new Treasury funds.

Although some efforts have been made by the government, they have been criticized by opposition parties, who say they have no idea how to deal with the problem. While critics said inflation was likely to stay around single digits for the foreseeable future, more needed to be done.

The NHS England prescription fee freeze will do little to appease critics with the same free prescriptions in countries of origin, while benefiting only some and not everyone.

Thanks for taking the time to read this article, don’t forget to come back and check the Euro Weekly News website for all your up to date local and international news and remember, you can also follow us on Facebook and Instagram .

Source link

9 AAPI-owned wellness brands to buy Sun, 15 May 2022 05:05:24 +0000

Be a chinese born american, I believe I have the best of both worlds – fusing the Chinese customs that my parents passed down to me and my sister with the American traditions. Growing up, I studied American history while learning to read and write Chinese. On my family’s Thanksgiving table, you’ll find the usual suspects (you know, turkey, mashed potatoes, and green bean casserole) interspersed with a Chinese version of stuffing, noodles, and a side dish of bok choy. .

In light of recent anti-Asian racism, I have never been prouder to be an Asian American. And as May marks Asian American and Pacific Islander (AAPI) Heritage Month, I thought what better way to honor and celebrate our cultures than to highlight wellness brands owned by American women. of Asian descent who inspire innovation, creativity and connection in our community and beyond. Keep reading to learn more about eight businesses to support today and every day.

From your skin to your period, Raël takes care of you. Founded by three women from South Korea, including CEO Yanghee Paik, who saw the need for quality feminine care in America, Rael combines high-quality organic materials from the United States with state-of-the-art Korean manufacturing technology. to create clean, sustainable and cruel products. free products for women. It’s a one-stop shop for women, by women.

Synonymous with self-care, the act of journaling has become a wellness trend you don’t want to sleep on. Enter: Silk + Sonder. Searching for a tool to help her overcome her feelings of anxiety and exhaustion and dissatisfaction, founder Meha Agrawal discovered the transformative nature of journaling and created a subscription-based journaling model to make personal care a more joyful and personalized experience. Choose from a monthly, quarterly, or annual subscription (included in every journal are guided prompts and wellness trackers).

Sisters Julie and Connie Kuo grew up in the male-dominated shoe industry and set out to set themselves and other women apart by producing sustainable shoes made from recycled plastic bottles. Short for authentic, versatile, responsible and self-sufficient, AVRE offers a stylish collection for different types of workouts, not to mention 3D technology that creates precise sizes, significantly reducing waste. Oh, and did I mention their shoes are machine washable?

After coming out of a toxic relationship and going through her own healing transformation through self-care and self-love, CEO and Founder Lin Chen launched Pink Moon to create a space of empowerment and abundance. Best described as a platform that blends emotional health and self-love with lasting beauty, Pink Moon curates a one-of-a-kind shopping experience showcasing women-led brands and their eco-conscious and ethical products. Talk about girl power. Browse gua sha tools, vegan lipsticks and nail polishes, scent oils, and more (they even have workshops!).

A cup of tea has always been more than just a drink for Sashee Chandran. Of Chinese and Sri Lankan descent, she has always viewed tea as a form of connection, community and nostalgia, bringing back fond memories of her childhood. Wanting to recreate the magic of a high quality tea experience she grew up with without the waste of tea bags, she created Tea Drops, an assortment of bagless, organic and whole leaf teas. Shop by tea type, flavor, caffeine content, benefit (immune support please!) and mood (can I get stress relief?).

When CEO and co-founder Sarah Paiji Yoo became a new mum, she was determined to find a solution to single-use plastic after learning that all the plastic thrown away contaminates the water and food she gives her baby. Born out of the lack of household products not wrapped in plastic, Blueland specializes in eco-friendly cleaning products that are as safe as they are effective. Their collection also includes essential hand soap, shower gel and laundry products, all without harmful chemicals, because a clean, non-toxic home means better health for you and the environment.

When Lulu Ge went off birth control and experienced debilitating cramps, bloating, headaches, and sleepless nights, she was determined to change the narrative around menstrual symptoms as an accepted part of just being a woman. Instead of masking the pain with toxic drugs and more synthetic contraceptives, she turned to herbal medicine and soon came up with the idea to create Elix to provide greater access to the holistic approach to wellness. be menstrual. With an online health assessment, you’ll get a personalized herbal treatment plan and be well on your way to achieving your healthiest cycle yet. Plus, all Elix offerings are 100% organic, ethically and sustainably sourced, vegan, and gluten-free.

After years of living off fast food, Julie Nguyen has compiled a long list of health issues. It wasn’t until she changed her diet that she realized the impact food can have on her health and well-being. Julie created Methodology, a weekly meal prep service, to help people take the guesswork out of how to create and maintain a healthy lifestyle so they can focus their time and energy elsewhere. Customize your subscription according to your food preferences, your cuisine, the days needed and the type of meal (breakfast, lunch, dinner, snack). The best part besides the convenience and delicious options? All food is pre-cooked and delivered in glass jars which are collected for recycling.

Daughter of a potter and a farmer, Shizu Okusa was influenced from an early age to appreciate and feel a connection to the Earth and nature. You won’t find any over-the-counter medicines in her house, but rather hot stones and herbal drinks. But his career hasn’t always matched his balanced upbringing. After working as a trader on Wall Street for three years, she knew she was destined for more. After quitting her job and traveling abroad where she learned Ayurveda, she eventually founded Apothekary. A plant-based “farm,” the brand offers herbal remedies and adaptogens (all organic, fair trade, and non-GMO) for everything from skin and gut health to sleep and libido.

20 Books by Asian American Authors You Need to Read
Source link

Andy Halliday denies suspicious Rangers minds as Hearts star brands split loyalty claiming ‘a bunch of nonsense’ Sun, 15 May 2022 05:00:00 +0000

Andy Halliday will be a radio pundit on Wednesday night openly declaring his wish to see Rangers beat Eintracht Frankfurt in the Europa League final in Seville.

The same guy will be a Hearts player on Saturday afternoon, doing everything he can to beat Rangers in the Scottish Cup final at Hampden.

If you suffer from a suspicious mind and don’t believe it’s true, that’s not Halliday’s problem.

There is a quote attributed to him that sums up his affinity with the Rangers.

“I wasn’t a Rangers fan from the day I was born,” he said. “It goes back further than that.”

But what Halliday won’t sit back and accept is being accused of being unprofessional in doing his job honestly against Giovanni van Bronckhorst’s side.

“Anyone who knows me well will understand that idea is a bunch of nonsense,” he says.

“Professional footballers play for the love of the game and because they are competitive by nature.

“There is no doubt what I will be trying to accomplish on May 21 and I know Hearts have a team that is more than capable of beating Rangers.

Get all the latest sports news straight to your inbox every day by signing up to our newsletter.

We cover every bit of information about your favorite club in the form of articles, videos and podcasts.

The newsletter will arrive daily at noon, giving you an overview of the best stories we’ve covered in the last 24 hours.

To register, simply enter your email address in the link here.

And if you’re not already, be sure to join the conversation on our Facebook and Record Sport Instagram groups.

“My motivation is that I’ve never won what I would call a meaningful trophy in my career – and I’m 30 now.”

One could easily argue that Hampden owes Halliday one to make up for a succession of heartaches suffered there.

He scored a superb goal for Rangers against Hibs at the National Stadium in the 2016 Scottish Cup final but considers that day one of the low points of his career.

“Any pro will tell you the lost cup finals are the ones you remember the most,” Halliday says.

“Rangers were 10 minutes away from winning the trophy and the memory of what happened next, and the crowd scenes at the final whistle that ruined the day still sting.” The same description could just as well apply to the infamous day when Rangers caretaker manager Graeme Murty replaced him two minutes before half-time, when Celtic were already two goals up at the half. -final.

Video loading

Video unavailable

Television images of the player raging against the manager’s decision remain vivid in the minds as opposition supporters ridicule him.

But his memories of Hoops fans singing “There’s Only One Andy Halliday” aren’t etched in his memory, whatever one might think.

“Look, I was lost in myself at that point,” he recalled.

“I thought the timing of the substitution was unnecessary, but I’m not the resentful type.

“I have since spoken to Graeme about what happened and he has apologized to me.

“I even understand where the Celtic fans were coming from that day. When I was in the stands at Ibrox for Old Firm games I sang about Neil Lennon every chance I got when he was a player.

“Then, as a player myself, I got to know him as a consummate professional and a stand up guy. It’s all part of the rivalry.

Halliday grew up in Govan. The Copland Road stand at Ibrox was at the end of his garden and he got his first season ticket when he was four years old.

“I wear my heart on my sleeve,” he says. “I remember going to my first Old Firm game and Celtic losing 3-1 at Ibrox.

“Walter Smith, God rest him, took off on the touchline in front of the fans after one of the goals and that mental image never left me.

“I spent five memorable years playing for Rangers but, over time, I developed a great love for Hearts.

“We will approach this cup final full of confidence, but we will not rely on what happens to Rangers in Sevilla to impact them in Hampden.

“Everyone thought 120 minutes against Braga at Ibrox in the quarter-finals would wreak havoc on them. It’s not.

Halliday might have attended the first leg of the Europa League semi-final against RB Leipzig, or even watched the game live on TV.

He did neither because, a few weeks earlier, I had asked him to help me organize a fundraiser for a school that helps children with learning difficulties and whose my daughter is part of the teaching staff.

I waited every day for the phone call to say he should cancel on me because of the date conflict.

He never came because he believed he was as good as his word.

Halliday is a walking case of mistaken identity.

The person I got to know working with him at Radio Clyde is nothing like the pantomime villain he seems to be to people all over the country.

“I can’t identify a date or a game when I acquired this image,” he says.

“But I never take anything personally.

“I live in the goldfish bowl of Glasgow, but I like to think I give respect and I get it back.

“I always believe in giving people the time of day because I was once a young fan and I remember what it was like to go and see players out of the park and hope a good reaction.”

He also remembers his parents allowing him to take a maths exam at school to accompany them to Manchester in 2008 for Rangers’ UEFA Cup final against Dick Advocaat’s Zenit St Petersburg.

It wasn’t the best of nights in the end, but Hearts can count on Halliday to test on their behalf at Hampden next weekend.

“There is a lot of growth in this team,” says the 30-year-old.

“And the future can be built on players who still have plenty of time left on their contracts.

“I recently signed a two-year extension myself and I feel fit enough to hope I can go beyond that as well.

“I lost a Scottish Cup final to Celtic when Covid meant there were no crowds there and it was a surreal experience for someone like me who thrives on the fact that fans make football.

“I intend to make up for that disappointment at Hampden when it sells out on Saturday.”

Source link

Low-cost prescription drugs protected by new Hunter Act Fri, 13 May 2022 22:39:43 +0000

SPRING FIELD – Access to low-cost prescription drugs will be protected through a measure led by State Sen. Mattie Hunter that was signed into law on Friday.

While the average adult spends $177 out of pocket on prescription drugs each year, affordability is a bigger issue for people who are older, on four or more prescription drugs, have chronic conditions, or have low incomes.

“People shouldn’t have to spend hundreds of dollars to get their prescription,” Hunter (D-Chicago) said. “People living with diseases and disorders need access to medicines, and we need to make them affordable for them.

New law protects access to low-cost “340B” prescription drugs for uninsured, low-income patients by prohibiting drug benefit managers and third-party payers from using certain contractual terms in contracts they enter into with health care providers benefiting from a safety net.

The federal 340B drug pricing program allows entities to stretch scarce federal resources as much as possible, reach more eligible patients, and provide more comprehensive services.

“Health care is a right, and that includes access to prescription drugs,” Hunter said. “The Drug Pricing Program was created to reduce drug costs for those who need them, and this measure reinforces that.

Similar measures have been adopted in 16 other states.

Due to an expanding aging population and an increase in chronic disease, health care costs in America have risen dramatically over the years, with costs expected to reach $6.2 trillion by 2028. L ‘Illinois spends more on prescription drugs than the majority of the nation, spending a total of $18.64 billion in 2019.

House Bill 4595 takes effect July 1, 2022.

Source link

Over-the-counter antibiotics for livestock will need to be prescribed by a veterinarian by 2023 Fri, 13 May 2022 22:25:00 +0000

CHATTANOOGA, Okla. (KSWO) – Changes are coming for ranchers and farmers who run small farms.

Over-the-counter livestock medications will require written prescriptions from veterinarians by 2023.

Right now, farmers can just walk into a farm supply store and buy the antibiotics they need to treat livestock and poultry, but by 2023 new Food and Drug Administration guidelines will require them to go a step further.

According to Chattanooga rancher Isaac Fisher, the change is likely to increase costs for those working in the ranching industry.

“Whenever you’re dealing with the health of a living organism, you don’t have extra time to waste, so if you don’t have access to it, you have to go get a script and it’s the weekend. end, well then it’s possible we could lose some livestock because of that,” Fisher said.

The FDA is concerned that antibiotic-resistant bacteria are growing faster because of the widespread use of certain medically important antibiotics in humans.

Fisher said this is just another inconvenience for breeders.

“At a time when food insecurity is causing so much concern around the world, and we’re making it harder for our farmers and herders to produce or do what we’re doing, and I don’t know what their thought process is and I don’t know. I don’t understand it, but it definitely makes it harder for us,” Fisher said.

Tri-County Cattlemen’s Association President Jeremy Kinder said it will include the most common antibiotics, such as penicillin and tetracyclines.

“Part of that is using certain products in these animals to make sure they’re healthy, thriving, and reaching their full genetic potential,” Kinder said. “The use of the antibiotic is really not going to change on our side of the scope. Yes, it’s one more hurdle to jump over, but we’ve seen it with VFDs and now we’re going to see the same thing with that basically.

Kinder said breeders will need to make sure they have established a good relationship with a local veterinarian.

“We struggle with a lot of things as growers here, especially in this part of the state with drought, water or power, it doesn’t matter,” Kinder said. “Pests and things like that, so we’re used to digging our heels in and getting things done and we’ll do that with that as well.”

Dr. Rector of Woodland Animal Hospital in Comanche said the change would be as simple as calling his office and making an appointment.

Copyright 2022 KSWO. All rights reserved.

Source link

Global brands place too much emphasis on China’s recovery Fri, 13 May 2022 10:08:14 +0000


LONDON (Reuters Breakingviews) – China’s Covid-19 “new normal” will test the hopes of Western multinationals for a rapid rebound in the world’s second-largest economy. Major groups ranging from Apple to General Electric /ge_webcast_presentation_04262022. pdf suffered a major hit to revenue in the first quarter as further lockdowns crippled factories and distribution networks and hurt retail sales. Many companies downplay the impact as temporary. It’s too optimistic.

Tracey Travis, CFO of Estée Lauder, probably isn’t the only one making a bold call *_ga*OTAwMjQyMzU1LjE2NTE2NjcwMDM.*_ga_V9QZ4PSDRY*MTY1MTg1NDE1NC41LjAuMTY1MTg1NDE1OC41Ng that China could reopen domestically in mid-May, and that pent-increased demand would help it recover recently lost sales. Le chiffre d’affaires du groupe américain de cosmétiques en Asie recule pour la première fois q3-fiscal-2022-earnings-release.pdf?_ga=2.83323606.1380716619.1651831252-900242355.1651667003&_gl=1*1ggbyh8*_ga*OTAwMjQyMzU1LjE2NTE2NjcwMDM.*_ga_V9QZ4PSDRY*MTY1MTg1NDE1NC41LjAuMTY1MTg1NDE2NS40OQ in two years in the three months to March. This was mainly due to China, where the company generates 36% of total sales, Jefferies analysts estimate. Remy Cointreau insists its growth potential for the year remains unchanged, even as the French premium liquor maker’s revenue fell in the quarter ended March, due to a double-digit decline as a percentage in China.

Reflection is based on past experience. Foreign companies in China have benefited from the country’s rapid recovery from the first wave of the pandemic. Authorities have also minimized economic damage by enacting targeted restrictions, particularly in the main production and logistics hub of Shanghai. The American and European Chambers of Commerce in China said most of their member companies remained profitable in 2020 and 2021.

But the Omicron outbreak that paralyzed Shanghai in March triggered a sea change in Beijing’s approach. Authorities have introduced regular mass testing in nearly a dozen of the country’s top cities by GDP, although no new cases are being reported. Residents must show a negative test result as often as every two days to enter public places. Inexpensive test kits will allow more cities to take the same approach.

In theory, this prevents another Shanghai-style surge. But it also makes reopening much more difficult. The harsh treatment of those who catch the virus can discourage people from traveling and spending.

China’s 400 million middle-class consumers make the country a key growth market for companies like Italian luxury goods maker Salvatore Ferragamo, which said on Tuesday it expects sales to double by four to five years from 2021. One option is to expand online sales and invest more in marketing, but even then Covid-19 restrictions may interfere with deliveries. The alternative is to cultivate new consumers in other countries. For now, however, companies are placing too much emphasis on China’s rapid recovery.

Follow @ywchen1 on Twitter


– World Health Organization Director-General Tedros Adhanom Ghebreyesus told a May 10 press conference that China’s zero-tolerance policy on Covid-19 is not “sustainable” given what is now known about the virus.

– Marco Gobbetti, managing director of Salvatore Ferragamo, pledged on May 10 to increase investment, reorganize stores and attract young customers to double revenues to nearly 2.3 billion euros by 2026. The Italian luxury group expects sales to rise in 2022 despite problems in China, where retail revenue fell in the first quarter due to new Covid-19 restrictions.

– Beijing on May 4 closed more than 60 subway stations and 158 bus lines. The Chinese capital on April 29 ordered its 22 million inhabitants to present a negative Covid test before entering public places.

– Estée Lauder’s sales in the Asia-Pacific region fell 4% in the first three months of 2022, the cosmetics group announced on May 3, mainly due to new restrictions put in place in China. Chief Financial Officer Tracey Thomas Travis told investors on a call that the company believes China could open in mid-May.

(Editing by Peter Thal Larsen, Katrina Hamlin and Oliver Taslic)

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Source link

Global Hearing Aids Market Competition Forecast and Opportunities to 2027 – Prescription Hearing Aids Expected to Hold Largest Revenue Share in Next Five Years – Fri, 13 May 2022 08:47:00 +0000

DUBLIN–(BUSINESS WIRE)–The “Global Hearing Aids Market, By Type (Prescription or Over-the-Counter), By Style, By Hearing Loss Types, By Product Type, By Technology Type, By Patient Type, By Distribution Channel, By Region, Competition Forecast and Opportunities, 2027” report has been added to from offer.

The value of the global hearing aids market could reach USD 29.58 billion by 2027F, growing at a CAGR of 7.7%, during the forecast period 2023-2027.

The market value in 2021 was USD 18.72 billion, the growth of the global hearing aids market can be attributed to the advancement of medical devices and increasing investment in the development of healthcare devices. The increase in demand for hearing aids may also be due to the increasing prevalence of hearing loss. Hearing loss can affect the geriatric population in large numbers, but due to certain environmental factors and genetic mutations, the disorders have also increased in children and young adults. Hence, growing geriatric population globally, increasing population of children born with hearing impairment and increasing cases of ear infection would further drive the growth of the global hearing aids market over the next five years.

Recent trends in the advancement of hearing aids have increased the demand for aesthetic devices which is supporting the growth of the market. Moreover, a thriving healthcare industry and increasing healthcare spending by governments and people across different regions is expected to drive the market growth over the forecast period.

The global hearing aids market is segmented on the basis of device type, type, style, hearing loss type, product type, technology type, patient type, distribution channel, business and regional distribution. Based on device type, the market is divided into prescription and over-the-counter drugs.

Prescription hearing aids are expected to hold the largest market revenue shares and dominate the market segment over the next five years due to increasing cases of hearing loss due to environmental factors and growing geriatric population being more susceptible to hearing loss.

Years considered for this report:

  • Historical years: 2017- 2020

  • Base year: 2021

  • Estimated year: 2022

  • Forecast period: 2023 – 2027

Goal of the study:

  • To analyze the market size of the global hearing aids market from 2017 to 2020.

  • Estimate and forecast the market size of global hearing aids market from 2021 to 2022 and the growth rate till 2027.

  • Classify and forecast the global hearing aids market based on device type, type, style, hearing loss type, product type, technology type, patient type, distribution channel, business and regional distribution.

  • To identify the dominant region or segment in the global hearing aids market.

  • Identify drivers and challenges in the global hearing aids market.

  • Examine competitive developments such as expansions, new product launches, mergers and acquisitions, etc., in the global hearing aids market.

  • To identify and analyze the profile of key players operating in the global Hearing Aids Market.

  • To identify the key sustainable strategies adopted by market players in the global Hearing Aids Market.

Report Scope:

Global hearing aid market, by device type:

  • Prescription based

  • Over the counter

Global Hearing Aids Market, By Type:

  • Hearing aids

  • behind the ears

  • In-ear hearing aids

  • Aids in the channel

  • Hearing aids

  • Hearing implants

Global hearing aid market, by type of hearing loss:

Global hearing aids market, by product type:

Global hearing aids market, by type of technology:

Global hearing aids market, by patient type:

Global Hearing Aids Market, By Distribution Channel:

Global Hearing Aids Market, By Region:

  • North America

  • United States

  • Canada

  • Mexico

  • Europe

  • Germany

  • Italy

  • UK

  • France

  • Spain

  • Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Australia

  • Indonesia

  • Philippines

  • Vietnam

  • South America

  • Brazil

  • Argentina

  • Colombia

  • Middle East and Africa

  • South Africa

  • United Arab Emirates

  • Saudi Arabia

  • Kuwait

Companies cited

  • Sonova Holding AG

  • Applicant A/S

  • GN Store North A/S

  • Cochlear Limited

  • Starkey Hearing Technologies

  • Rion Co., Ltd.

  • WS Audiology A/S

  • Medtronic Plc.

  • Amplifon SpA

  • Eargo Inc.

For more information about this report visit

About is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and the latest trends.

Source link